English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18054/20253 (89%)
Visitors : 24250970      Online Users : 586
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34698

    標題: BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
    作者: Wu, Cheng-Kuei
    Wei, Man-Ting
    Wu, Hung-Chang
    Wu, Cheng-Lin
    Wu, Cheng-Ju
    Liaw, Hungjiun
    Su, Wen-Pin
    貢獻者: National Cheng Kung University
    Chi Mei Hospital
    Department of Pharmacy, Chia Nan University of Pharmacy & Science
    National Cheng Kung University
    National Cheng Kung University Hospital
    National Cheng Kung University
    National Cheng Kung University Hospital
    National Cheng Kung University
    National Cheng Kung University Hospital
    National Cheng Kung University
    關鍵字: bone morphogenetic protein-2
    breast-cancer cells
    日期: 2022
    上傳時間: 2023-12-11 14:05:44 (UTC+8)
    摘要: Bone morphogenetic protein 2 (BMP2) is highly overexpressed in human non-small cell lung cancer (NSCLC) and correlates with tumor stage and metastatic burden. Although several lines of evidence suggest that BMP2 promotes cell migration and invasiveness in vitro, the in vivo role of BMP2 in the metastasis of lung adenocarcinoma cells remains less well understood. Here, we revealed that BMP2 is highly overexpressed in lung adenocarcinoma patients with lymph node metastasis compared with patients without lymph node metastasis. Using an in vivo orthotopic mouse model, we clearly demonstrated that BMP2 promotes lung adenocarcinoma metastasis. The depletion of BMP2 or its receptor BMPR2 significantly reduced cell migration and invasiveness. We further identified that BMP2/BMPR2-mediated cell migration involves the activation of the SMAD1/5/8 signaling pathway, independent of the KRAS signaling pathway. Significantly, the depletion of SMAD1/5/8 or the inhibition of SMAD1/5/8 by LDN193189 inhibitor significantly reduced cell migration. These findings show that BMP2 promotes NSCLC metastasis, indicating that targeting the BMP2 signaling pathway may represent a potential therapeutic strategy for treating patients with metastatic NSCLC.
    關聯: SCIENTIFIC REPORTS, v.12, n.16310
    Appears in Collections:[藥學系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    s41598-022-20788-2.pdf14355KbAdobe PDF62View/Open

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback